JCR Pharmaceuticals Co., Ltd.
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1975-01-01
- Employees
- 934
- Market Cap
- -
- Website
- http://www.jcrpharm.co.jp
Clinical Trials
36
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials
An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06488924
- Locations
- 🇯🇵
Hiroshima University Hospital, Hiroshima, Japan
🇯🇵University of the Ryukyus Hospital, Okinawa, Japan
🇯🇵National Center for Child Health and Development, Tokyo, Japan
Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-08-26
- Lead Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT06095388
- Locations
- 🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT05594992
- Locations
- 🇺🇸
UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇦🇷Hospital Universitario Austral, Buenos Aires, Argentina
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
- Conditions
- Mucopolysaccharidosis II
- Interventions
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT04573023
- Locations
- 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT04453085
- Locations
- 🇺🇸
UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
🇧🇷Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
🇧🇷Instituto de Genética e Erros Inatos do Metabolismo - IGEIM, São Paulo, Brazil
- Prev
- 1
- 2
- 3
- Next